These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 22738896
21. Muscarinic agonists and antagonists: effects on the urinary bladder. Sellers DJ, Chess-Williams R. Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707 [Abstract] [Full Text] [Related]
22. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Liu HT, Lin H, Kuo HC. Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717 [Abstract] [Full Text] [Related]
23. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder. Juszczak K, Ziomber A, Wyczółkowski M, Thor PJ. Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976 [Abstract] [Full Text] [Related]
24. The pharmacotherapy of overactive bladder. Athanasopoulos A. Expert Opin Pharmacother; 2011 May; 12(7):1003-5. PubMed ID: 21291348 [Abstract] [Full Text] [Related]
26. Control of bladder function by peripheral nerves: avenues for novel drug targets. Fry CH, Ikeda Y, Harvey R, Wu C, Sui GP. Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649 [Abstract] [Full Text] [Related]
27. Pharmacotherapy of the overactive bladder. Andersson KE. Discov Med; 2009 Oct; 8(42):118-24. PubMed ID: 19833057 [Abstract] [Full Text] [Related]
29. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. Nitti VW, Rovner ES, Bavendam T. BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062 [Abstract] [Full Text] [Related]
35. Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity. Radziszewski P, Crayton R, Zaborski J, Członkowska A, Borkowski A, Bossowska A, Majewski M. Mult Scler; 2009 Jul; 15(7):860-8. PubMed ID: 19542265 [Abstract] [Full Text] [Related]
37. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. Palleschi G, Pastore AL, Stocchi F, Bova G, Inghilleri M, Sigala S, Carbone A. Clin Neuropharmacol; 2006 Jul; 29(4):220-9. PubMed ID: 16855424 [Abstract] [Full Text] [Related]
39. Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity. Ronchi P, Gravina GL, Galatioto GP, Costa AM, Martella O, Vicentini C. Neurourol Urodyn; 2009 Jul; 28(1):52-7. PubMed ID: 18671288 [Abstract] [Full Text] [Related]
40. The afferent system and its role in lower urinary tract dysfunction. Daly DM, Collins VM, Chapple CR, Grundy D. Curr Opin Urol; 2011 Jul; 21(4):268-74. PubMed ID: 21537194 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]